olmesartan has been researched along with Autoimmune Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barge, S; Nault, JC; Ziol, M | 1 |
Fincher, K; Mangin, M; Sinha, R | 1 |
Heil, TJR; Marshall, TG | 1 |
Albert, PJ; Perez, TH; Waterhouse, JC | 1 |
Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
1 review(s) available for olmesartan and Autoimmune Diseases
Article | Year |
---|---|
Inflammation and vitamin D: the infection connection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Bacterial Infections; Humans; Imidazoles; Inflammation; Receptors, Calcitriol; Tetrazoles; Vitamin D; Vitamin D Deficiency | 2014 |
5 other study(ies) available for olmesartan and Autoimmune Diseases
Article | Year |
---|---|
Autoimmune-like chronic hepatitis induced by olmesartan.
Topics: Antihypertensive Agents; Autoimmune Diseases; Chemical and Drug Induced Liver Injury, Chronic; Humans; Imidazoles; Male; Middle Aged; Tetrazoles | 2017 |
Electrosmog and autoimmune disease.
Topics: Autoimmune Diseases; Environmental Exposure; Humans; Imidazoles; Immunomodulation; Microwaves; Receptors, Calcitriol; Tetrazoles | 2017 |
Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Reactive; Arthritis, Rheumatoid; Autoimmune Diseases; Bacterial Infections; Calcifediol; Calcitriol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Imidazoles; Minocycline; Psoriasis; Receptors, Calcitriol; Sarcoidosis; Scleroderma, Systemic; Sjogren's Syndrome; Spondylitis, Ankylosing; Tetrazoles; Thyroid Diseases; Uveitis | 2009 |
Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Blotting, Western; Chemokine CCL2; Endoplasmic Reticulum; Heart; Heart Failure; Imidazoles; Immunohistochemistry; Interferon-gamma; Interleukin-1beta; Male; Myocarditis; Myocardium; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Tumor Necrosis Factor-alpha | 2011 |
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autoimmune Diseases; Cardiotonic Agents; Endoplasmic Reticulum Stress; Heart Failure; Imidazoles; Inflammation; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Myocarditis; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptors, Interleukin-1; RNA, Messenger; Tetrazoles | 2012 |